BiotechTube
Home/Pipeline/MUTI™ Drug‑Eluting Stent

MUTI™ Drug‑Eluting Stent

Coronary Artery Disease

CommercialActive

Key Facts

Indication
Coronary Artery Disease
Phase
Commercial
Status
Active
Company
Meril

About Meril

Indian medtech leader delivering affordable orthopedic, cardiovascular and wound‑care devices for emerging markets.

View full company profile

Therapeutic Areas

OrthopedicsCardiovascularWound Care

Other Coronary Artery Disease Drugs

DrugCompanyPhase
Coronary Artery Bypass GraftsVascudynePre-clinical
Premier DESRelisys Medical DevicesCommercial
Release R DESRelisys Medical DevicesCommercial
Pristine DESRelisys Medical DevicesCommercial
BioMatrix family (Flex/Alpha)Biosensors InternationalCommercial
Coronary Artery Disease ProgramElixir MedicalPre-clinical
Essential pro StentiVascularUPost-Market
FGF-1Zhittya Genesis MedicinePhase 2
OMT-28OMEICOS TherapeuticsPhase 2
Fantom EncoreREVA MedicalCommercial
Next-Gen Drug-Eluting StentsTransluminaDevelopment
Geographic Market ExpansionTransluminaCommercial